+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
FEMALE
ID06816095

Molecular Analysis of Ozone Therapy Response in Women with Gynecological Tumors Experiencing Chronic Pelvic Pain After Cancer Treatment

Led by Bernardino Clavo, MD, PhD · Updated on 2026-09-25

40

Participants Needed

1

Research Sites

25 weeks

Total Duration

AI-Summary

What This Trial Is About

Gynecological cancers such as ovarian, uterine, and cervical cancers significantly impact womens health, particularly through chronic pelvic pain caused by treatments like radiotherapy and chemotherapy. This pain is often difficult to manage and can reduce quality of life. Researchers are studying how ozone therapy, a complementary treatment, affects gene expression and epigenetic changes to better understand its role in pain relief. The study observes two groups of adult women with gynecological tumors treated by radiotherapy or chemotherapy those with chronic pelvic pain receiving compassionate ozone therapy and those without such pain. No experimental treatments are given as part of the study patients continue with their standard care. The research focuses on analyzing gene expression and biological age through epigenetic clocks before and after ozone therapy in the pain group, comparing these markers between the two groups. Participants will be evaluated at the start and after 16 weeks, with assessments including gene expression, biological age markers, pain scores, quality of life questionnaires, toxicity grading, and biochemical markers of oxidative stress and inflammation. The study aims to link these molecular changes to clinical outcomes to better predict pain responses. The total study duration extends until August 2027, with ongoing monitoring of patient health and well-being throughout.

CONDITIONS

Brief Title

Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment

Research Team

B

Bernardino Clavo, MD, PhD

F

Francisco Rodríguez-Esparragón, BSc, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here